Skip to content

Christina Xiang Gu

NPI 1104575000ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Stanford, CA

Internal Medicine, Endocrinology, Diabetes & Metabolism in Stanford, California, licensed in CA, with an NPI issued in March 2022. Part D covered 330 prescriptions written in 2024, 92% of them generic. Kiniksa Pharmaceuticals International, PLC reported $25.04 in payments in 2024, mostly food and beverage.

Overview

NPI1104575000
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedMar 20, 2022
Last updated in NPPESOct 8, 2026
Certified by providerOct 8, 2026

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)330 · 821 30-day fills
Patients59
Total drug cost$17,689
Generic share92% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2024$25.04 · 1 payment from 1 company

Top paying companies in 2024

CompanyAmountPayments
Kiniksa Pharmaceuticals International, PLC$25.041

What the 2024 payments were for

  • Food and Beverage$25.04 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Stanford

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in California →